Skip to main content

Characterization of DJ-1 Null Transgenic Mice

The protein DJ-1 has been implicated to play a role in neurodegenerative diseases, such as multiple system atrophy and Parkinson's disease (PD). Mutations in the DJ-1 gene have been linked to an autosomal recessive early onset form of parkinsonism and presumably result in diminished or completely attenuated DJ-1 activity. A growing body of evidence suggests that DJ-1 may be involved in protecting neurons from mitochondrial dysfunction and oxidative damage. This proposal builds directly on the recent Michael J. Fox Foundation Transgenic Initiative, which resulted in the generation of transgenic mice with reduced and null DJ-1 expression. The purpose of this proposal is two-fold: 1) to characterize any pathology which may develop in heterozygous and homozygous null expressors, with specific emphasis on the nigral dopaminergic neurons and 2) to determine whether the lack of DJ-1 renders the nigrostriatal pathway more sensitive to injury elicited through neurotoxicant exposure or proteasomal impairment. The proposed studies will determine whether the null DJ-1 transgenics provide a relevant new model for studying the development of PD-like pathology and for assessing the role of DJ-1, specifically, in the events involved in nigral dopaminergic cell degeneration.


  • Donato A. Di Monte, MD

    Bonn Germany

  • Amy Manning-Bog, PhD

    Menlo Park, CA United States

Discover More Grants

Within the Same Program

Within the Same Funding Year

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.